The bill helps veterans access and discuss State-authorized cannabis without losing VA benefits and improves clinical guidance, but it creates legal tensions with federal drug law, raises privacy risks for medical records, and adds administrative burdens for VA providers.
Veterans who participate in State marijuana programs can keep their VA benefits, removing a barrier that previously deterred some veterans from seeking or continuing care.
VA clinicians can discuss, document, and recommend participation in State-approved marijuana programs, enabling more informed, safer treatment planning and improving veterans' access to clinical guidance about cannabis.
Veterans and VA clinicians may face legal tension because recommending or facilitating participation in State marijuana programs conflicts with federal law that still classifies marijuana as a Schedule I substance.
Documenting marijuana use in VA medical records could raise privacy concerns for veterans if records are accessed by third parties (e.g., employers, insurers), potentially exposing them to stigma or adverse consequences.
Expanding VA clinician roles to discuss and recommend cannabis may increase administrative workload and require new training and resources for VHA providers, straining staff and budgets.
Based on analysis of 2 sections of legislative text.
Prevents VA benefit denial solely for participation in State-approved marijuana programs and lets VA clinicians discuss, document, and recommend participation.
Introduced February 4, 2025 by W. Greg Steube · Last progress February 4, 2025
Allows the Department of Veterans Affairs to treat a veteran’s participation in a State-approved marijuana program as not, by itself, a reason to deny VA-administered benefits, and permits VA health care providers to discuss, record, and offer recommendations or opinions about such participation for enrolled veterans. The bill defines marijuana and State by cross-reference to existing federal definitions and does not create new funding or change federal criminal law or drug scheduling.